Adverse Drug Events in Older Hospitalized Patients: Results and Reliability of a Comprehensive and Structured Identification Strategy

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Klopotowska, Joanna E ^a   Wierenga, Peter C ^a,b   Stuijt, Clementine C M ^a   Arisz, Lambertus ^a   Dijkgraaf, Marcel G W ^a   Kuks, Paul F M ^a   Asscheman, Henk ^c   de Rooij, Sophia E ^a   Lie A Huen, Loraine ^d   Smorenburg, Susanne M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b DEVENTER HOSPITAL   (Netherlands)

^c HAJAP   (Netherlands)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG FATALITY; FEMALE; HOSPITAL PATIENT; HUMAN; INTERRATER RELIABILITY; INTRARATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICATION ERROR; STRATEGIC PLANNING;

EID: 84881097566     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071045     Document Type: Article

References (73)

1. Thomas EJ, Brennan TA, (2000) Incidence and types of preventable adverse events in elderly patients: population based review of medical records. BMJ 320: 741-744.
2. De Vries EN, Ramrattan MA, Smorenburg SM, Gouma DJ, Boermeester MA, (2008) The incidence and nature of in-hospital adverse events: a systematic review. Qual Saf Health Care 17: 216-223.
3. Zegers M, De Bruijne MC, Wagner C, Hoonhout LHF, Waaijman R, et al. (2009) Adverse events and potentially preventable deaths in Dutch hospitals: results of a retrospective patient record review study. Qual Saf Health Care 18: 297-302.
4. Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, et al. (1991) The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 324: 377-384.
5. Thürmann PA, (2003) Detection of drug-related adverse events in hospitals. Expert Opin Drug Saf 2: 447-449.
6. Hoonhout LHF, De Bruijne MC, Wagner C, Asscheman H, Van der Wal G, et al. (2010) Nature, occurrence and consequences of medication-related adverse events during hospitalization: a retrospective chart review in the Netherlands. Drug Saf 33: 853-864.
7. Evans RS, Lloyd JF, Stoddard GJ, Nebeker JR, Samore MH, (2005) Risk factors for adverse drug events: a 10-year analysis. Ann Pharmacother 39: 1161-1168.
8. Lazarou J, Pomeranz BH, Corey PN, (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279: 1200-1205.
9. McLean AJ, Le Couteur DG, (2004) Aging biology and geriatric clinical pharmacology. Pharmacol Rev 56: 163-184.
10. Hartholt KA, Van der Velde N, Looman CWN, Panneman MJM, Van Beeck EF, et al. (2010) Adverse drug reactions related hospital admissions in persons aged 60 years and over, The Netherlands, 1981-2007: less rapid increase, different drugs. PloS One 5: e13977.
11. Steinman MA, Hanlon JT, (2010) Managing Medications in Clinically Complex Elders: "There is Got to Be a Happy Medium". JAMA 304: 1592-1601.
12. Spinewine A, (2008) Adverse Drug Reactions in Elderly People: The challenge of safer prescribing. BMJ 336: 956-957.
13. Expert Group On Safe Medication Practices (2006). Creation of a better medication safety culture in Europe: Building up safe medication practices. Strasbourg, France. 38 p.
14. Kanjanarat P, Winterstein AG, Johns TE, Hatton RC, Gonzalez-Rothi R, et al. (2003) Nature of preventable adverse drug events in hospitals: a literature review. Am J Health Syst Pharm 60: 1750-1759.
15. Bates DW, Leape LL, Petrycki S, (1993) Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med 8: 289-294.
16. Egger T, Dormann H, Ahne G, Runge U, Neubert A, et al. (2003) Identification of adverse drug reactions in geriatric inpatients using a computerised drug database. Drugs Aging 20: 769-776.
17. Gray SL, Sager M, Lestico MR, Jalaluddin M, (1998) Adverse drug events in hospitalized elderly. J Gerontol A Biol Med Sci 53: M59-M63.
18. Trivalle C, Cartier T, Verny C, Mathieu A-M, Davrinche P, et al. (2010) Identifying and preventing adverse drug events in elderly hospitalised patients: a randomised trial of a program to reduce adverse drug effects. J Nutr Health Aging 14: 57-61.
19. Tangiisuran B, Davies JG, Wright JE, Rajkumar C, (2012) Adverse drug reactions in a population of hospitalized very elderly patients. Drugs & aging 29: 669-679.
20. Brown C, Hofer T, Johal A, Thomson R, Nicholl J, et al. (2008) An epistemology of patient safety research: a framework for study design and interpretation. Part 3. End points and measurement. Qual Saf Health Care 17: 170-177.
21. Kaushal R, (2002) Using chart review to screen for medication errors and adverse drug events. Am J Health Syst Pharm 59: 2323-2325.
22. Lilford RJ, Mohammed MA, Braunholtz D, Hofer TP, (2003) The measurement of active errors: methodological issues. Qual Saf Health Care 12Suppl 2: ii8-12.
23. Morimoto T, Gandhi TK, Seger AC, Hsieh TC, Bates DW, (2004) Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care 13: 306-314.
24. Nebeker JR, (2002) Developing a Taxonomy for Research in Adverse Drug Events: Potholes and Signposts. J Am Med Inform Assoc 9(Suppl 2): 80-85.
25. Macedo AF, Marques FB, Ribeiro CF, (2006) Can decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs? Drug Saf 29: 697-702.
26. Murff HJ, Patel VL, Hripcsak G, Bates DW, (2003) Detecting adverse events for patient safety research: a review of current methodologies. J Biomed Inform 36: 131-143.
27. Egbring M, Far E, Knuth A, Roos M, Kirch W, et al. (2011) Performance of different data sources in identifying adverse drug events in hospitalized patients. Eur J Clin Pharmacol 67: 909-918.
28. Agbabiaka TB, Savović J, Ernst E, (2008) Methods for causality assessment of adverse drug reactions: a systematic review. Drug Saf 31: 21-37.
29. Arimone Y, Miremont-Salamé G, Haramburu F, Molimard M, Moore N, et al. (2007) Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions. Br J Clin Pharmacol 64: 482-488.
30. Rozich JD, Haraden CR, Resar RK, (2003) Adverse drug event trigger tool: a practical methodology for measuring medication related harm. Qual Saf Health Care 12: 194-200.
31. Neale G, Woloshynowych M, (2003) Retrospective case record review: a blunt instrument that needs sharpening. Qual Saf Health Care 12: 2-3.
32. Resar RK, Rozich JD, Classen D, (2003) Methodology and rationale for the measurement of harm with trigger tools. Qual Saf Health Care 12Suppl 3: 39-45.
33. Institute for Helathcare Improvement (2004) Trigger Tool for Measuring Adverse Drug Events. Available: http://www.ihi.org/knowledge/Pages/Tools/TriggerToolforMeasuringAdverseDrugEvents.aspx. Accessed 2013 Apr 16.
34. Franklin BD, Birch S, Schachter M, Barber N, (2010) Testing a trigger tool as a method of detecting harm from medication errors in a UK hospital: a pilot study. Int J Pharm Pract 18: 305-311.
35. Klopotowska JE, Wierenga PC, De Rooij SE, Stuijt CC, Arisz L, et al. (2011) The effect of an active on-ward participation of hospital pharmacists in Internal Medicine teams on preventable Adverse Drug Events in elderly inpatients: protocol of the WINGS study (Ward-oriented pharmacy In Newly admitted Geriatric Seniors). BMC Health Serv Res 11: 124.
36. Zegers M, De Bruijne MC, Wagner C, Groenewegen PP, Waaijman R, et al. (2007) Design of a retrospective patient record study on the occurrence of adverse events among patients in Dutch hospitals. BMC Health Serv Res 7: 27.
37. Phansalkar S, Hoffman JM, Nebeker JR, Hurdle JF, (2007) Pharmacists versus nonpharmacists in adverse drug event detection: a meta-analysis and systematic review. Am J Health Syst Pharm 64: 842-849.
38. Van Doormaal JE, Mol PGM, Van Den Bemt PMLA, Zaal RJ, Egberts ACG, et al. (2008) Reliability of the assessment of preventable adverse drug events in daily clinical practice. Drug Saf 17: 645-654.
39. The G-Standaard: the medicines standard in healthcare. Available: http://www.knmp.nl/downloads/producten-diensten/g-standaard-1/algemeen/GStandaarddecisionsupportversionoct2011.pdf. Accessed 2013 Jun 18.
40. Van der Sijs H, Mulder A, Van Gelder T, Aarts J, Berg M, et al. (2009) Drug safety alert generation and overriding in a large Dutch university medical centre. Pharmacoepidemiol Drug Saf 18: 941-947.
41. Committee of Experts on Management of Safety and Quality in Health Care (SP-SQS), Expert Group on Safe Medication Practices (2005) Glossary of terms related to patient and medication safety. Strasbourg, France. p 16.
42. The Uppsala Monitoring Centre. The use of the WHO-UMC system for standardised case causality assessment. Available: http://who-umc.org/Graphics/24734.pdf. Accessed 2013 Apr 16.
43. Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events v3.0. 0. Available: http://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcaev3.pdf. Accessed 2013 Apr 16.
44. Dutch Hospital Pharmacists Association. Centrale Medicatiefouten Registratie (CMR). The Hague, The Netherlands.
45. Dutch Drug Information. Available: http://kennisbank.knmp.nl. Accessed 2013 Apr 16.
46. Kunac DL, Reith DM, Kennedy J, Austin NC, Williams SM, (2006) Inter- and intra-rater reliability for classification of medication related events in paediatric inpatients. Qual Saf Health Care 15: 196-201.
47. Page RL, Ruscin JM, (2006) The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. Am J Geriatr Pharmacother 4: 297-305.
48. Azad N, Tierney M, Victor G, Kumar P (2002) Adverse drug events in the elderly population admitted to a tertiary care hospital. J Healthc Manag 47: 295-305; discussion 305-6.
49. Bowman L, Carlstedt BC, Hancock EF, Black CD, (1996) Adverse drug reaction (ADR) occurrence and evaluation in elderly inpatients. Pharmacoepidemiol Drug Saf 5: 9-18.
50. Harugeri A, Joseph J, Parthasarathi G, Ramesh M, Guido S, (2010) Potentially inappropriate medication use in elderly patients: a study of prevalence and predictors in two teaching hospitals. J Postgrad Med 56: 186-191.
51. Passarelli MCG, Jacob-Filho W, Figueras A, (2005) Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging 22: 767-777.
52. Bates DW, (2002) Using information technology to screen for adverse drug events. Am J Health Syst Pharm 59: 2317-2319.
53. Kilbridge PM, Campbell UC, Cozart HB, Mojarrad MG, (2006) Automated surveillance for adverse drug events at a community hospital and an academic medical center. J Am Med Inform Assoc 13: 372-377.
54. Michel P, Quenon JL, De Sarasqueta AM, Scemama O, (2004) Comparison of three methods for estimating rates of adverse events and rates of preventable adverse events in acute care hospitals. BMJ 328: 199.
55. Gallagher PF, O'Connor MN, O'Mahony D, (2011) Prevention of Potentially Inappropriate Prescribing for Elderly Patients: A Randomized Controlled Trial Using STOPP/START Criteria. Clin Pharmacol Ther 89: 845-854.
56. Thomsen LA, Winterstein AG, Søndergaard B, Haugbølle LS, Melander A, (2007) Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother 41: 1411-1426.
57. Kaushal R, Bates DW, Landrigan C, McKenna KJ, Clapp MD, et al. (2001) Medication errors and adverse drug events in pediatric inpatients. JAMA 285: 2114-2120.
58. Manias E (2012) Detection of medication-related problems in hospital practice: a review. Br J Clin Pharmacol Nov 30.
59. Wolfstadt JI, Gurwitz JH, Field TS, Lee M, Kalkar S, et al. (2007) The effect of computerized physician order entry with clinical decision support on the rates of adverse drug events: a systematic review. J Gen Intern Med 23: 451-458.
60. Kuperman GJ, Bobb A, Payne TH, Avery AJ, Gandhi TK, et al. (2007) Medication-related clinical decision support in computerized provider order entry systems: a review. J Am Med Inform Assoc 14: 29-40.
61. Van der Sijs H, Aarts J, Vulto A, Berg M (n.d.) Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc 13: 138-147.
62. Page RL, Linnebur SA, Bryant LL, Ruscin JM, (2010) Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions. Clin Interv Aging 5: 75-87.
63. Bakker FC, Robben SHM, Olde Rikkert MGM, (2011) Effects of hospital-wide interventions to improve care for frail older inpatients: a systematic review. BMJ Qual Saf 20: 680-691.
64. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA, (2003) Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med 163: 2014-2018.
65. Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, et al. (2009) A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med 169: 894-900.
66. Spinewine A, Swine C, Dhillon S, Lambert P, Nachega JB, et al. (2007) Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc 55: 658-665.
67. Doloresco F, Vermeulen LC, (2009) Global survey of hospital pharmacy practice. Am J Health Syst Pharm 66: S13-9.
68. Besdine R, Boult C, Brangman S, Coleman EA, Fried LP, et al. (2005) Caring for older Americans: the future of geriatric medicine. J Am Geriatr Soc 53: S245-56.
69. Tinetti ME, Fried TR, Boyd CM, (2012) Designing health care for the most common chronic condition-multimorbidity. JAMA 307: 2493-2494.
70. Hofer TP, Bernstein SJ, DeMonner S, Hayward RA, (2000) Discussion between reviewers does not improve reliability of peer review of hospital quality. Medical Care 38: 152-161.
71. Baker R, Camosso-Stefinovic J, Gillies C, Shaw EJ, Cheater F, et al. (2010) Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes. Cochrane Database Syst Rev: CD005470.
72. Luck J, Peabody JW, Dresselhaus TR, Lee M, Glassman P, (2000) How well does chart abstraction measure quality? A prospective comparison of standardized patients with the medical record. Am J Med 108: 642-649.
73. Anatomical Therapeutic Chemical (ATC) classification by World Health Organization Collaborating Centre for Drug Statistics Methodology. Available: http://www.whocc.no/atc_ddd_index/. Accessed 2013 Jun 18.